[{"address1": "1 Enterprise Drive", "address2": "Suite 430", "city": "Shelton", "state": "CT", "zip": "06484-4779", "country": "United States", "phone": "203 221 7381", "fax": "203 557 3023", "website": "https://www.intensitytherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Lewis H. Bender M.A., M.B.A., M.S.", "age": 66, "title": "Founder, President, CEO & Chairman of the Board", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 597007, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph  Talamo CPA, M.B.A.", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 416930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Wesolowski CPA, M.B.A.", "age": 65, "title": "Principal Accounting Officer & Controller", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 260898, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James M. Ahlers", "age": 61, "title": "Executive Vice President of Corporate Finance", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 75088, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.3711, "open": 0.28, "dayLow": 0.245, "dayHigh": 0.2898, "regularMarketPreviousClose": 0.3711, "regularMarketOpen": 0.28, "regularMarketDayLow": 0.245, "regularMarketDayHigh": 0.2898, "payoutRatio": 0.0, "beta": 4.219, "forwardPE": -1.1372727, "volume": 9128560, "regularMarketVolume": 9128560, "averageVolume": 2028683, "averageVolume10days": 1599800, "averageDailyVolume10Day": 1599800, "bid": 0.2012, "ask": 0.3224, "bidSize": 2, "askSize": 2, "marketCap": 15028254, "fiftyTwoWeekLow": 0.185, "fiftyTwoWeekHigh": 2.5, "allTimeHigh": 11.44, "allTimeLow": 0.185, "fiftyDayAverage": 0.40944, "twoHundredDayAverage": 0.36926, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 8079254, "profitMargins": 0.0, "floatShares": 54782852, "sharesOutstanding": 60064965, "sharesShort": 1158529, "sharesShortPriorMonth": 1865400, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.019299999, "heldPercentInsiders": 0.08794, "heldPercentInstitutions": 0.078940004, "shortRatio": 0.92, "shortPercentOfFloat": 0.02, "impliedSharesOutstanding": 60064965, "bookValue": 0.147, "priceToBook": 1.7020408, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -11736000, "trailingEps": -0.55, "forwardEps": -0.22, "52WeekChange": -0.87684727, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 0.2502, "targetHighPrice": 5.0, "targetLowPrice": 1.5, "targetMeanPrice": 2.9, "targetMedianPrice": 3.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 7067000, "totalCashPerShare": 0.118, "totalDebt": 118000, "quickRatio": 3.105, "currentRatio": 3.597, "debtToEquity": 1.634, "returnOnAssets": -1.01661, "returnOnEquity": -2.34697, "freeCashflow": -5259875, "operatingCashflow": -9500000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "INTS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Intensity Therapeutics, Inc.", "longName": "Intensity Therapeutics, Inc.", "marketState": "CLOSED", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2028683, "fiftyTwoWeekLowChange": 0.0652, "fiftyTwoWeekLowChangePercent": 0.35243243, "fiftyTwoWeekRange": "0.185 - 2.5", "fiftyTwoWeekHighChange": -2.2498, "fiftyTwoWeekHighChangePercent": -0.89992, "fiftyTwoWeekChangePercent": -87.68472, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754596800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.55, "epsForward": -0.22, "epsCurrentYear": -0.34333, "priceEpsCurrentYear": -0.728745, "fiftyDayAverageChange": -0.15924, "fiftyDayAverageChangePercent": -0.38892147, "twoHundredDayAverageChange": -0.11906001, "twoHundredDayAverageChangePercent": -0.32242864, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-06-30", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "exchange": "NCM", "messageBoardId": "finmb_225412349", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -32.5788, "regularMarketPrice": 0.2502, "corporateActions": [{"header": "Reverse stock split", "message": "INTS announces 1 for 25 split effective Feb. 19, 2026", "meta": {"eventType": "SPLIT", "dateEpochMs": 1771477200000, "splitRatio": "1:25"}}], "postMarketTime": 1771030712, "regularMarketTime": 1771016403, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1688131800000, "postMarketChangePercent": -5.2757792, "postMarketPrice": 0.237, "postMarketChange": -0.0132, "regularMarketChange": -0.1209, "regularMarketDayRange": "0.245 - 0.2898", "displayName": "Intensity Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-02-14"}]